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A Health System-Wide Problem 
 
In 2007, the U.S. spent nearly $2.3 trillion on health care and public and private insurers 
processed more than 4 billion health insurance claims.1 The National Health Care Anti-Fraud 
Association (NHCAA) has estimated that, conservatively, 3% of all health care spending—or 
$68 billion—is lost to health care fraud. Other estimates by government and law enforcement 
agencies place fraud-related losses as high as 10% of annual health care spending;2 at this rate, 
the losses in 2007 alone –over $220 billion – would have been enough to cover the uninsured. 
 
What is absolutely clear from virtually every reliable source on the subject is that health care 
fraud is a systemic problem affecting public and private insurers alike, in the individual market, 
the employer-sponsored group market, and public programs. Because Medicare and Medicaid 
are government-sponsored and thus are required to report on fraud, the problem is perhaps better 
known, but combating fraud is a challenge that faces both public and private insurers. Indeed, 
one survey found that since 1995, 90% of all private insurers have launched anti-fraud 
campaigns.3 
 
The failure to systematically and routinely measure the scope of fraud is characteristic of the 
insurance industry as a whole, and it is not limited to the United States.4 Numerous government 
agencies have reported that no segment of the health care delivery system is immune from fraud5 
                                                 
1 National Health Care Anti-Fraud Association. The Problem of Health Care Fraud. Consumer Alert found at: 
http://www.nhcaa.org/eweb/DynamicPage.aspx?webcode=anti_fraud_resource_centr&wpscode=TheProblemOfHC
Fraud  
2 Ibid. See also Federal Bureau of Investigation, Financial Crimes Report to the Public, Fiscal Year 2007.  Available 
at: http://www.fbi.gov/publications/financial/fcs_report2007/financial_crime_2007.htm 
3 Cohen EL, Cesta TG. Evolution of nursing case management in a changing health care system. In: Cohen EL, Cesta TG, 
eds. Nursing case management: from essentials to advanced practice applications. 4th ed. St. Louis, MO: Mosby, 
2004:399. 
4 Clarke, M., “The Control of Insurance Fraud: A Comparative View,” The British 
Journal of Criminology, 30(1)(Winter 1990): 2. 
5 “Health Care Fraud, Hearing before the Senate Select Comm. On Aging.” 104th Cong.,1st sess. (March 21, 1995) 
(prepared statement of FBI Director Louis J. Freeh). 
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and that instance of fraud and abuse can be found involving all segments of the health care 
industry and in every geographical area of the country.6  
 
Fraud is Not Improper Payment 
 
Black’s Law Dictionary defines fraud as “a knowing misrepresentation of the truth or 
concealment of a material fact to induce another to act to his or her detriment.” Improper 
payments or overpayments may not involve fraud at all if a payment simply was made or 
claimed in error. The law equates fraud with an intent to conceal or deceive or acting in a manner 
that conveys a reckless disregard for the truth of one’s claims.  
 
In the context of health insurance, fraud may manifest itself as deception of a public or private 
health insurer into paying claims that are not owed, or a reckless disregard for the truthfulness of 
claims that are submitted. Insurers have also been found to have engaged in fraud against group 
sponsors and members, by conspiring to overcharge plan members in relation to the benefits that 
were promised. This type of fraud is essentially an intentional manipulation of the claims 
payment process for financial gain through bribes, kickbacks, and racketeering.   
 
Fraud is distinct from improper payments under public programs, which can arise from simple 
errors in documentation, coding, reporting, verification, and other technical matters related to the 
administration of public programs. Improper payments are reported annually by federal agencies 
under the Improper Payment Improvement Act of 2002 (IPIA).7 In recent years, as agencies 
increasingly have implemented the law, the amount of reported improper payments has risen and 
efforts have been undertaken to correct the underlying program administration standards and 
procedures that give rise to improper payments.8  
 
How Widespread is Health Insurance Fraud and What Forms Does it Take? 
 
Examples of fraudulent activity consist of fraudulent billing, kickbacks, up-coding services, 
bundling, and ghost patients. Estimates are that 80% of healthcare fraud is committed by medical 
providers, 10 percent by consumers, and the balance by others, such as insurers themselves and 
their employees. 9  
 
Table 1 presents an illustrative overview of the types of fraudulent conduct that have been 
pursued in court or reported in the press in recent years. These examples have been drawn from a 
systematic search of reported actions using legal search engines, as well as a review of legal 
journal and news articles on health care fraud-related actions. The types of fraud recovery 
actions described in Table 1 might be pursued privately by health insurers as civil fraud cases, 
while state Attorneys General or the United States Department of Justice also have wide-ranging 
powers under state and federal law to pursue health care fraud under numerous legal theories.  
 
                                                 
6 GAO. Health Insurance: Vulnerable Payers Lose Billions to Fraud and Abuse 2 (1992). 
7 P.L. 107-300 (107th Cong., 1st sess.) 
8 GAO, Improper Payments: Progress Made but Challenges Remain in Estimating and Reducing Improper Payments 
(GAO-09-628T) (April 22, 2009) 
9 Coalition Against Insurance Fraud. Go Figure: fraud data. Available at: www.insurancefraud.org/stats.htm  
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These cases suggest that the most common type of fraud involves systematically overcharging 
insurers for the cost of items and services for which payment is specified either by contract or in 
law. Thus, for example, many pharmaceutical companies have been pursued by Medicaid 
programs for failing to adhere to federal prescription drug rebate requirements, with resulting 
major overcharges to state agencies. (Because the Centers for Medicare and Medicaid Services 
have not yet reported on cases of either improper payment or fraud under the Medicare Part D 
program,10 it is not possible to know the magnitude of such practices under Medicare). Similarly, 
hospitals have been charged with systematically upcoding Medicare claims to falsely elevate the 
cost of care.  
 
Perhaps the most striking examples of fraud are those that involve the private health insurance 
industry itself. In these cases, the deception can involve either overstating the insurer’s costs in 
paying claims, or systematically and deceptively under-valuing the amount owed by the insurer 
to a health care provider -- all with the intention of shifting increased responsibility for the cost 
of care to the plan member and group sponsor, in ways that violate the terms of the contract: 
 
 In one recent New York case reported prominently in the press,11 leading private insurers 
were found to have manipulated the prices they paid for physician services in order to 
systematically drive down the amount they owed for out-of-network physician care and 
thereby drive up members’ financial exposure for the balance. This intentional 
manipulation of provider payments resulted in an estimated 10% to 28% increase in 
members’ direct financial exposure for the cost of out-of-network care. 
 
 A major hospital corporation-affiliated private insurer was found to have intentionally 
misrepresented in its bills to plan members the true price of its own hospitals’ care, while 
secretly negotiating deep discounts with its hospitals. As a result, plan members were 
actually paying the majority of the hospital bills they incurred rather than the 20% copay 
they were promised.12  
 
Vulnerable Populations Are the Most Likely Fraud Victims, Regardless of Whether the 
Fraud is Public or Private  
 
Medicare and Medicaid may be susceptible to fraud in part because many investigative reports 
on victims of consumer swindles suggest that financial fraud is not uniformly distributed across 
all households; instead, it disproportionately targets the elderly, women, minorities, the less 
educated, and the poor.13 In other words, Medicare and Medicaid fraud may reflect the 
vulnerable nature of the populations that depend on the program rather than any failing on the 
part of either program. As a result, simply moving away from Medicare and Medicaid coverage 
and toward a system of private health insurance subsidies would in and of itself do nothing to 
curb fraud; it simply would privatize the victimizing of the poor and vulnerable. 
 
                                                 
10 GAO, Progress Made, supra note 
11 The American Medical Association v. United Healthcare Corporation, et al., 2009 U.S. Dist. LEXIS 45610 
(S.D.N.Y May 7, 2009). 
12 Humana Inc. v. Forsyth, 525 U.S. 299 (1999);119 S. Ct. 710; 142 L. Ed. 2d 753. 
13 Lee, J., & Soberon-Ferrer, H. (1997). Consumer vulnerability to fraud: influencing factors. Journal of Consumer 
Affairs, 31(1), 70-89.   
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policy attention to fraud grows, these recovery figures can be expected to increase 
ill further.   
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What Have Medicare and Medicaid Done to Combat Fraud?  
 
Federal law contains extensive provisions to combat fraud in Medicare and Medicaid. Federal 
laws impose both civil and criminal liability for false claims, bribes and kickbacks, and 
racketeering. The Health Insurance Portability and Accountability Act of 199614 created the 
Health Care Fraud and Abuse Control Program (under joint direction of Attorney General and 
Secretary of Dept. of Health and Human Services), a far-reaching program to combat fraud and 
abuse in health care, including both private and public health insurance plans. In FY 2007: the 
federal government won or negotiated approximately $1.8 billion in judgments and 
15se
 
Similarly, the Deficit Reduction Act of 200516 contains provisions aimed at strengthening 
Medicaid anti-fraud protections. The provisions provide economic incentives to states that enact 
state false claims laws f
m
 
Finally, 2009 legislation amending the Civil False Claims Act (Fraud Enforcement and Recovery 
Act (FERA)17 expands
in
 
Table 2 shows the past decade of fraud recoveries. As the Table indicates, Medicaid recoveries 
have steadily increased as the laws have been toughened. As the impact of the 2006 reforms and 
greater public 
st
 
C
 
Fraud – whether committed by health care providers, plan members, or insurers themselves – is 
an unfortunate but real part of the health care landscape. As the national health reform legislation 
takes shape, keeping an attentive eye on anti-fraud provisions will be a critical element of 
reform. Since the victims of fraud are disproportionately likely to be lower income and 
vulnerable populations, the central issue will be not whether public programs serve as the basis 
of expanded insurance program but whether anti-fraud safeguards are a firm, fixed feature of 
final reform legislation. This means considering steps to strengthen the reach and scope of the 
HIPAA insurance fraud provisions of 1996, including strong protections related to marketing, 
enrollment, consumer protections, health care access, and claims payment into final legislation, 
requiring anti-fraud compliance procedures for all insurers participating in a reformed health care 
system, and sufficiently funding fede
 
14 P.L. 104-191 (104th Cong., 2d Sess.) 
15 Ibid. 
16 P.L. 109-171 (109th Cong. 2d Sess.) 
17 Senate Bill 386, 111th Congress (May 20, 2009). 
Table 1.  Health Care Fraud Across the Health Care Industry: Private Health Insurance, Medicare, and Medicaid 
Private Health Insurance -  Medicare  Medicaid  
ACCUSED COMPANY INDUSTRY TYPE OF FRAUD RECOVERY 
UnitedHealth1 Managed Care Underpaid consumers (10%-
28%) by manipulating database 
it used to pay customers for out-
of-network services  
$350 million 
McKesson2 Pharmaceutical Fraudulently inflated prices of 
approximately 450 drugs 
charged to insurers and 
consumers 
$350 million3 
HealthNet4 Managed Care ERISA and RICO violations by 
underpaying consumers in 
several states 
$215 million 
Cleveland Clinic5 Integrated Health Care 
System 
Medical identity theft; false 
claims 
Unknown 
Tenet6 Hospital False claims, Kickbacks $900 million 
TAP Pharmaceuticals7 Pharmaceutical False claims, Conspiracy, 
kickbacks 
$ 559.5 million 
St. Barnabas Hospitals8 Hospital False claims $265 million 
HCA9 Hospital False claims, kickbacks $631 million 
HealthSouth10 Rehabilitative Medicine 
Services 
False claims $325 million 
Ciena Healthcare 
Management, Inc.11 
Nursing Home False claims from inadequate 
care in nutrition and hydration, 
the assessment and evaluation of 
needs, care planning and nursing 
interventions, medication 
management, fall prevention, 
and pressure ulcer care, 
including the prevention  
and treatment of wounds. 
$1.25 million12 
                                                            
1 American Medical Association v. United Healthcare Corp., 588 F.Supp.2d 432 (S.D.N.Y. 2008) 
2 New England Carpenters Health Benefits Fund, et al. v. First DataBank, Inc. and McKesson Corp., 244 F.R.D. 79 (D. Mass. August 27, 2007) 
3 This settlement is a preliminary court approved settlement entered on March 31, 2009 and the hearing on final approval is scheduled for July 23, 
2009.  Available at: http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aVpLVzpsq1NI. 
4 Wachtel v. Health Net; McCoy v. Health Net; and Scharfman v. Health Net, 239 F.R.D. 81 (D. N.J. December 6, 2006). 
5 Walecia Ronrad, A New Ailment: Medical ID Theft, N.Y. Times, June 13, 2009. 
6 United States v. Tenet Healthcare Corp., C. A. No. 03-206 (C.D. Cal. Jan. 9, 2003). 
7 United States ex rel. Durand v. TAP Pharmaceuticals, CA No. 00-12618-GAO (filed May 1996 in the E.D. Pa., later transferred to D. Mass, 
settled Sept. 28, 2001). 
8 United States ex rel. Monahan v. St. Barnabas Health Care System, Inc., C.A. No. 02-5702 (D.N.J. June 15, 2006). 
 
9 United States, ex. rel. Alderson, v. Columbia/HCA Corporation, Case No. 99-3290 (RCL), part of Case No. 01-MS-50 (RCL) (D. D.C. 2003). 
10 United States ex rel. James Devage v. HealthSouth Corporation, et al., Civ. Action No. SA-98-CA-0372FB (W.D. Tex.).; United States ex rel. 
Manning v. HealthSouth Corporation, (W.D. Tex.); and United States ex rel. Brupbacher & Associates and Michael C. Freeman v. National 
Institutional Pharmacy Services, Inc. (D. N. Mex.) (cases settled Dec. 30 2004). 
11 U.S. ex rel. Denise Hubbard v. Ciena Healthcare Management, et al., CV-03-60175 (E.D. Mich.). 
12 This case involves fraud against both the Medicare and Medicaid programs. 
 
ACCUSED COMPANY INDUSTRY TYPE OF FRAUD RECOVERY 
United Health Group and 
other insurers13 
Insurance  Fraud, misrepresentation, 
deception through use of 
company-owned Ingenix system 
to systematically undervalue its 
payment obligations for 
physician services in order to 
shift the cost of out-of-network 
coverage from the insurer to 
members and plan sponsors 
Approximately $100 million 
Humana Insurance Fraud, deception involving  
concealment of the actual cost of 
hospital services from plan 
members 
 
Amerigroup14 Insurance/Managed Care False claims involving the 
treatment of pregnant women 
and other patients  
$225 million 
Merck15 Pharmaceutical False claims,  
Kickbacks 
$650 million 
Serono Group16 
AstraZenica Pharmaceuticals17 
Wyeth18 
Pharmaceutical 
 
False claims, Kickbacks $567 million 
$160 million 
Qui tam action pending 
Bristol-Meyers Squibb19, KV 
Pharmaceuticals, Roxane 
Laboratories, Abbott 
Laboratories, Aventis 
Pharmaceutical, Teva 
Pharmaceuticals, Schering 
Plow/Warrick, Forest 
Laboratories, Baxter 
International, Dey 
Pharmaceuticals, Bayer 
Pharmaceuticals 
Pharmaceutical False Claims $123.75 million 
Omnicare, Inc. 20 Pharmaceutical False claims by replacing brand-
name with generic drugs or 
switching dosage strengths  
$49.5 million 
 
 
                                                            
13 The American Medical Association v. United Healthcare Corporation, et al., 2009 U.S. Dist. LEXIS 45610 (S.D.N.Y May 7, 2009). 
14 United States, ex rel. Tyson, et al. v. Amerigroup Illinois, Inc., et al., 2007 WL 781729 (N.D.Ill. March 13, 2007).  
15 State of Nevada ex rel. Steinke v. Merck & Company, Inc., 2006 WL 1506901(D. Nev. May 31, 2006). 
16 United States ex rel. Driscoll v. Serono Laboratories,, Inc., C.A. No. 00-11680 (D. Mass. August 17, 2000). 
17 Alabama v AstraZenica, [reported in] BNA, 18 Health Law Reporter (June 3, 2009). 
18 United States. ex. Rel. Kieff v Wyeth, C.A. No. 03-12366DPW (D. Mass); USDOJ intervention May 18, 2009, [reported in] BNA Health Law 
Reporter 18:687 (June 3, 2009). 
19 Alabama v Abbott Laboratories, No. CV-05-219 (Ala. Cir., Ct. May 22, 2009), [reported in] BNA Health Law Reporter 18: 685 BNA) (June 3, 
2009). 
20 United States et al., ex rel. Bernard Lisitza v. Omnicare, Inc., 01 C 7433, and United States et al., ex rel. David Kammerer v. Omnicare, Inc., 04 
C 2074 (N.D. Il.). 
 Table 2.  Federal Health Care Fraud and Abuse Program Recoveries by Fiscal Year1 
 
 
                                                            
1 Chart made with data published in the Health Care Fraud and Abuse Control Program Reports from fiscal year 
2000-07 available at http://www.oig.hhs.gov/publications/hcfac.asp.  
